Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss, anti-viral, anti-TB, animal healthcare, and others. The company also exports its products to approximately 70 countries worldwide. The company was founded in 1956 and is headquartered in Taizhou, China.
Metrics to compare | 600267 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600267PeersSector | |
---|---|---|---|---|
P/E Ratio | 24.3x | 26.7x | −0.5x | |
PEG Ratio | 0.03 | 0.18 | 0.00 | |
Price/Book | 1.6x | 2.8x | 2.6x | |
Price / LTM Sales | 1.4x | 3.2x | 3.3x | |
Upside (Analyst Target) | −37.5% | 2.1% | 42.9% | |
Fair Value Upside | Unlock | 9.2% | 6.2% | Unlock |